Skip to main content

Peer Review reports

From: Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial

Original Submission
22 Jun 2020 Submitted Original manuscript
30 Jun 2020 Reviewed Reviewer Report
5 Jul 2020 Reviewed Reviewer Report
27 Jul 2020 Author responded Author comments - Young-Il Kim
Resubmission - Version 2
27 Jul 2020 Submitted Manuscript version 2
18 Oct 2020 Reviewed Reviewer Report
25 Oct 2020 Reviewed Reviewer Report
1 Nov 2020 Reviewed Reviewer Report
26 Nov 2020 Author responded Author comments - Young-Il Kim
Resubmission - Version 3
26 Nov 2020 Submitted Manuscript version 3
15 Feb 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
18 Feb 2021 Editorially accepted
2 Mar 2021 Article published 10.1186/s12876-021-01680-1

You can find further information about peer review here.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us